Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma

British Journal of Cancer

Volumn 75, Issue 11, 1997, Pages 1674-1677

  Rasmuson, T ^a   Grankvist, K ^a   Ljungberg, B ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

c erbB 2; HER 2 neu; Oncoprotein; Prognosis; Renal cell carcinoma

Indexed keywords

ONCOPROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0030992674     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.284     Document Type: Article

References (29)

1. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC and McGuire WL (1992) Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 23: 974-979
2. Carney WP, Hamer PJ, Petit D, Retos C, Greene R, Zabrecky JR, McKenzie S, Hayes D, Kufe D, DeLellis R, Naber S and Wolfe H (1991) Detection and quantification of the human neu oncoprotein. J Tumor Marker Oncol 6: 53-72
3. neu) in normal and transformed epithelial tissues of the digestive tract. Oncogene 4: 81-88
4. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A and Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139
5. Freeman MR, Washecka R and Chung LWK (1989) Abberant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers. Cancer Res 49: 6221-6225
6. Herrera GA (1991) C-erb B-2 amplification in cystic renal disease. Kidney International 40: 509-513
7. Kandl H, Seymour L and Bezwoda WR (1994) Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer. Br J Cancer 70: 739-742
8. Leitzel K, Teramoto Y, Sampson E, Mauceri J, Langton BC, Demers L, Podczaski E, Harvey H, Shambaugh S, Volas G, Weaver S and Lipton A (1992) Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. J Clin Oncol 10: 1436-1443
9. Lupu R, Cardillo M, Harris L, Hijazi M and Rosenberg K (1995) Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance. Semin Cancer Biol 6: 135-145
10. neu in human ovarian cancer. Cancer 71: 3942-3946
11. McKenzie SJ, Marks PJ, Lam T, Morgan J, Panicali DL, Trimpe KL and Carney WP (1989) Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p 185. Oncogene 4: 543-548
12. Mori S, Mori Y, Mukaiyama T, Yamada Y, Sonobe Y, Matsushita H, Sakamoto G, Akiyama T, Ogawa M, Shiraishi M, Toyoshima K and Yamamoto T (1990) In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells. Jpn J Cancer Res 81: 489-494
13. Press MF, Corbon-Cardo C and Slamon DJ (1990) Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5: 953-962
14. Robson CJ, Churchill BM and Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101: 297-301
15. Rotter M, Block T, Busch R, Thanner S and Höfler H (1992) Expression of HER-2/neu in renal-cell carcinoma. Correlation with histologic subtypes and differentiation. Int J Cancer 52: 213-217
16. Schechter AL, Hung M-C, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A and Coussens L (1985) The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229: 976-978
17. Skinner DG, Colvin RB, Vermillion CD, Pfister RC and Leadbetter WF (1971) Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28: 1165-1177
18. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182
19. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712
20. Sprent P (1989) Applied Nonparametric Statistical Methods. Chapman & Hall: London
21. Stumm G, Eberwein S, Rostock-Wolf S, Stein H, Pomer S, Schlegel J and Waldherr R (1996) Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis. Int J Cancer 69: 17-22
22. Tandon AK, Clark GM, Chamness GC, Ullrich A and McGuire WL (1989) HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7: 1120-1128
23. Thrasher JB and Paulson DF (1993) Prognostic factors in renal cell cancer. Urol Clin North Am 20: 247-262
24. van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O and Nusse R (1988) Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 319: 1239-1245
25. Weidner U, Peter S, Strohmeyer T, Hussnätter R, Ackermann R and Sies H (1990) Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma. Cancer Res 50: 4504-4509
26. Venter DJ, Tuzi NL, Kumar S and Gullik WJ (1987) Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 2: 69-72
27. Yao M, Shuin T, Misaki H and Kubota Y (1988) Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer. Cancer Res 48: 6753-6757
28. Yokota J, Yamamoto T, Toyoshima K, Terada M, Sugimura T, Battifora H and Cline MJ (1986) Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1: 765-767
29. Zabrecky JR, Lam T, McKenzie SJ and Carney W (1991) The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells. SK-BR-3. J Biol Chem 266: 1716-1720